1500 Participants Needed

SINCERE Intervention for COVID-19 Health Disparities

(SINCERE Trial)

EJ
EG
Overseen ByErnest Grigorian
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Andrea Wallace
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to see if checking people's social needs, connecting them with community services, and providing ongoing support can help prevent COVID-19 spread and improve health. It focuses on those who are vulnerable to COVID-19 and face economic challenges. By understanding their needs and providing support, the goal is to help them access necessary services and improve their overall well-being.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Is the SINCERE Intervention generally safe for humans?

The research articles reviewed do not provide specific safety data for the SINCERE Intervention or its related programs. They focus on addressing social needs and health disparities, but do not mention any safety concerns related to the intervention itself.12345

How is the SINCERE treatment different from other COVID-19 treatments?

The SINCERE treatment is unique because it focuses on addressing social needs like food and housing insecurity, which can impact health outcomes, rather than just medical symptoms. It involves screening for these needs and connecting patients to community resources, making it different from traditional medical treatments that focus solely on the virus itself.16789

What data supports the effectiveness of the SINCERE Intervention for COVID-19 Health Disparities treatment?

Research shows that addressing health-related social needs, like food and housing insecurity, can improve health outcomes during public health emergencies. Programs that use telehealth follow-ups and community service referrals have been effective in identifying and addressing these needs, which are important components of the SINCERE Intervention.157810

Who Is on the Research Team?

AW

Andrea Wallace, PhD

Principal Investigator

University of Utah

Are You a Good Fit for This Trial?

This trial is for adults over 17 who have social needs and are willing to get help from community services after visiting certain emergency departments or COVID-19 testing sites. They must be reachable by phone or able to complete surveys online, and speak English or Spanish. It's not for those in nursing homes or unable to communicate verbally.

Inclusion Criteria

I am older than 17 years.
You have completed the referral process at specific medical facilities and have indicated that you need and are willing to receive low-cost or free services from the United Way 211 community referral service.
I can be contacted by phone or can complete surveys via text or email.

Exclusion Criteria

I live in a nursing facility or need help with daily activities.
Those unable to communicate verbally

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive universal social needs screening, community-based service referrals, and telephonic follow-up as part of the SINCERE intervention

12 weeks
Baseline, 2-week, 4-week, and 12-week surveys

Follow-up

Participants are monitored for changes in global health, anxiety, and depression over the intervention period

12 weeks
Scheduled follow-up calls

What Are the Treatments Tested in This Trial?

Interventions

  • Scheduled Follow-Up
  • SINCERE
  • Standard of Care
Trial Overview The SINCERE intervention includes universal screening for social needs, referrals to community services, and follow-up calls. The study tests if these steps can prevent COVID-19 spread among vulnerable groups and improve health outcomes following the pandemic's socioeconomic impacts.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Call + Resources + Scheduled Follow-UpExperimental Treatment1 Intervention
Group II: Call + Resources + SINCEREExperimental Treatment1 Intervention
Group III: Call + ResourcesActive Control1 Intervention

SINCERE is already approved in United States for the following indications:

🇺🇸
Approved in United States as SINCERE Intervention for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

Andrea Wallace

Lead Sponsor

Trials
3
Recruited
11,100+

National Institute of Nursing Research (NINR)

Collaborator

Trials
623
Recruited
10,400,000+

Published Research Related to This Trial

A telehealth follow-up program in Boston successfully reached 509 patients discharged after COVID-19 testing, identifying 41.1% of them as having unmet health-related social needs (HRSNs), primarily related to food, housing, or utilities.
The program also identified 6.1% of patients who required further clinical assessment due to worsening symptoms, highlighting its potential effectiveness in addressing both health and social needs during public health emergencies.
The Health and Social Needs of Patients Discharged From the Emergency Department With Suspected COVID-19.Khidir, H., DeLuca, M., Macias-Konstantopoulos, WL., et al.[2023]
The COVID-19 pandemic has increased health-related social needs (HRSNs) like food insecurity and housing instability, emphasizing the importance of addressing these issues, especially in communities facing health disparities.
The Accountable Health Communities Model provides effective strategies for implementing HRSN screening in clinical settings, such as enhancing patient engagement through culturally tailored outreach and integrating screening into existing workflows.
Health-Related Social Needs Screening: Promising Practices From the Accountable Health Communities Model.Bosold, A., Abrams Weintraub, T., Cowen, K., et al.[2023]
In a pilot study involving 1,135 hospitalized patients, 54% completed a screening for social determinants of health (SDOH), revealing that 45% had at least one social need related to food, housing, or transportation.
The study found that Medicaid beneficiaries and Black patients were more likely to report multiple SDOH needs, highlighting the importance of addressing these factors in discharge planning and community resource linkage.
Addressing social risk factors in the inpatient setting: Initial findings from a screening and referral pilot at an urban safety-net academic medical center in Virginia, USA.Chukmaitov, A., Dahman, B., Garland, SL., et al.[2022]

Citations

The Health and Social Needs of Patients Discharged From the Emergency Department With Suspected COVID-19. [2023]
Health-Related Social Needs Screening: Promising Practices From the Accountable Health Communities Model. [2023]
Addressing social risk factors in the inpatient setting: Initial findings from a screening and referral pilot at an urban safety-net academic medical center in Virginia, USA. [2022]
Preventing Unequal Health Outcomes in COVID-19: A Systematic Review of Past Interventions. [2022]
Accelerating integration of social needs into mainstream healthcare to achieve health equity in the COVID-19 era. [2023]
Estimating the effects of race and social vulnerability on hospital admission and mortality from COVID-19. [2022]
The prevalence of social care in US health care settings depends on how and whom you ask. [2020]
Comparison of Community-Level and Patient-Level Social Risk Data in a Network of Community Health Centers. [2021]
Engaging Community Health Workers and Social Care Staff as Social First Responders during the COVID-19 Crisis. [2021]
10.United Statespubmed.ncbi.nlm.nih.gov
The COVID-19 Shadow Pandemic: Meeting Social Needs For A City In Lockdown. [2020]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security